Stomach cancer is a type of cancer that affects the lining of the stomach. It is a serious and life-threatening condition, but it can be treated if caught early. Unfortunately, many cases of stomach cancer go undetected until the cancer has advanced and become more difficult to treat. It is important for doctors to be aware of the subtle signs and symptoms of stomach cancer so that they can diagnose and treat it as soon as possible.
Stomach cancer is more common among people over the age of 50, although it can affect people of all ages. Other risk factors for stomach cancer include a family history of the disease, a diet high in smoked, salty, or pickled foods, and long-term infection with bacteria such as Helicobacter pylori. Smoking and excessive alcohol consumption are also risk factors for stomach cancer.
The signs and symptoms of stomach cancer can be subtle and may not be noticed until the cancer has advanced. Common symptoms include abdominal pain, nausea, vomiting, loss of appetite, weight loss, fatigue, and a feeling of fullness in the abdomen. Additionally, some people may experience blood in their stool, a change in bowel habits, or a lump in the abdomen.
If a doctor suspects that a patient may have stomach cancer, they will order tests such as an endoscopy, a CT scan, an MRI, or a biopsy to confirm the diagnosis. Once the diagnosis is confirmed, the doctor will develop a treatment plan. Treatment options may include surgery, chemotherapy, radiation therapy, or a combination of these.
Stomach cancer is a serious and life-threatening condition, but it can be treated if caught early. Unfortunately, many cases of stomach cancer go undetected until the cancer has advanced and become more difficult to treat. It is important for doctors to be aware of the subtle signs and symptoms of stomach cancer so that they can diagnose and treat it as soon as possible. Early diagnosis and treatment can improve the chances of successful treatment and a positive outcome.
1.
Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca
2.
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer
3.
Asymptomatic Brain Metastases in EGFR-Mutant NSCLC
4.
Mapping lifelong chronic health risks for childhood cancer survivors
5.
Adding Chemo to Osimertinib Doubles PFS in Advanced NSCLC
1.
Respiratory Ramifications of Systemic Disease: A Comprehensive Review
2.
Revolutionizing Lung Cancer Treatment: Exploring the Benefits of Wedge Resection Surgery
3.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
4.
Cancer Care Advances: Metformin, Digital Tools, and Artificial Renal Support
5.
Molecular Mechanisms, Clinical Efficacy, and Stem Cell Therapy Integration in Leukemia Treatment
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Treatment Paradigm for Patients with R/R Adult B-cell ALL- Expert Discussions
2.
First Line Combination Therapy- The Overall Survival Data in NSCLC Patients
3.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
4.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
5.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation